NR6A1 acts as a repressor of mTOR activity: low levels of NR6A1 contribute to mTOR activation, favoring the transcription of pro-tumor genes related to lipogenesis, angiogenesis, and NFkB signaling (40) (Figure 3D). The gene discussed is MTOR; the disease is neoplasm.